CD276 and osteosarcoma: These B7-H3 CAR-T cells exhibit limited activity against K562 xenografts with low B7-H3 expression (4750 molecules per cell), while inducing significant regression of MG63.3 osteosarcoma, which expresses higher levels of B7-H3 (93,544 molecules per cell).